Myles J. Smith, MB BCh BAO, PhD, FRCSI, FRCS

Consultant Surgical Oncologist and General Surgeon,
Department of Surgery, The Royal Marsden Hospital and Institute of Cancer Research
London, England, United Kingdom

Myles Smith, MD, FRCS is a Consultant Surgical Oncologist at The Royal Marsden Hospital and Reader at the Institute of Cancer Research, London. His clinical practice focuses on melanoma and soft tissue sarcoma, with a particular interest in precision surgery, sentinel lymph node biopsy, and complex oncologic decision-making. His research programme integrates surgical oncology with advanced imaging, artificial intelligence, and mixed-reality guidance to improve intraoperative accuracy and patient outcomes. He is actively involved in national and international guideline development and leads multiple translational and clinical research collaborations across the UK, Europe, and the United States.

Presentation(s):

• P41. Predictors of manufacturing success after tumor tissue procurement for tumor infiltrating lymphocyte cell therapy

  Thursday, March 5, 2026
  2:25 PM - 2:32 PM MST

• P75. The role of cemiplimab in treating locally advanced cutaneous SCC: a UK single centre experience and the implications for surgical management.

  Thursday, March 5, 2026
  4:16 PM - 4:23 PM MST